Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces

Caley, Matthew P; King, Helen; Shah, Neel; Wang, Kai; Rodríguez Teja, Mercedes; Gronau, Julian H; Waxman, Jonathan; Sturge, Justin.
Clin. exp. metastasis ; 33: 151-165, 2016. ilus
Artículo en Inglés | URUCAN | ID: bcc-5066

Documentos relacionados

  1. Rediscovering Secondary Tumors of the Prostate in the Molecular Era.
  2. Vinculin orchestrates prostate cancer progression by regulating tumor cell invasion, migration, and proliferation.
  3. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth
  4. Circulating tumor cells and circulating tumor DNA.
  5. Development and Application of Liquid Biopsies in Metastatic Prostate Cancer.
  6. Profiling oxylipins released from human platelets activated through the GPVI collagen receptor.
  7. Radical prostatectomy in oligometastatic prostate cancer.
  8. Biallelic BRCA2 Mutations Shape the Somatic Mutational Landscape of Aggressive Prostate Tumors.
  9. Metastasis-Directed Therapy in Prostate Cancer. Why, When, and How?
  10. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer.